Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Traffic (Copenhagen, Denmark)|September 28, 2007
AAA+ ATPases: achieving diversity of function with conserved machinerySusan Roehl White, Brett LauringJournal of Structural Biology|March 27, 2012
Crystal structure of the human spastin AAA domainJennifer L Taylor, Susan Roehl White, Brett Lauring, et al.The Journal of Cell Biology|March 29, 2007
Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severingSusan Roehl White, Katia J Evans, Jeffrey Lary, et al.Journal of Cell Science|June 15, 2007
Climp-63-mediated binding of microtubules to the ER affects the lateral mobility of translocon complexesAndrei V Nikonov, Hans-Peter Hauri, Brett Lauring, et al.The Journal of Biological Chemistry|March 1, 2003
Parkinson's disease-associated alpha-synuclein is a calmodulin substrateJessica Martinez, Ines Moeller, Hediye Erdjument-Bromage, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2006
Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenanceKatia Evans, Christian Keller, Karen Pavur, et al.Endocrinology|June 11, 2005
Cholesterol and steroid synthesizing smooth endoplasmic reticulum of adrenocortical cells contains high levels of proteins associated with the translocation channelVirginia H Black, Archana Sanjay, Klaus van Leyen, et al.Diabetes, Obesity & Metabolism|February 9, 2018
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension studyRonnie Aronson, Juan Frias, Allison Goldman, et al.Cell|July 7, 2010
The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to ciliaHua Jin, Susan Roehl White, Toshinobu Shida, et al.Diabetes, Obesity & Metabolism|January 8, 2019
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trialSilvina Gallo, Bernard Charbonnel, Allison Goldman, et al.Pageof 4